University of Groningen
The first case of ischemia-free organ transplantation in humans
van Leeuwen, Otto B.; Ubbink, Rinse; de Meijer, Vincent E.; Porte, Robert J.
Published in:
American Journal of Transplantation
DOI:
10.1111/ajt.14869
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2018
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
van Leeuwen, O. B., Ubbink, R., de Meijer, V. E., & Porte, R. J. (2018). The first case of ischemia-free
organ transplantation in humans: A proof of concept. American Journal of Transplantation, 18(8),
2091-2091. https://doi.org/10.1111/ajt.14869
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.
Am J Transplant. 2018;18:2091. amjtransplant.com
|
2091 DOI: 10.1111/ajt.14869L E T T E R T O T H E E D I T O R
The first case of ischemia‐free organ transplantation in
humans: A proof of concept
With great interest we have read the article by Xiaoshun He and colleagues regarding their first patient who underwent successful ischemia- free organ transplantation (IFOT).1 This group transplanted
a liver donated after brain death to a 51- year- old patient with decom-pensated cirrhosis and hepatocellular carcinoma without any ischemic episode or interruption of the blood circulation. The graft was pro-cured, ex- situ preserved, and implanted under continuous normother-mic machine perfusion using the Liver Assist device (Organ Assist, Groningen, The Netherlands). The donor liver had 85%- 95% macrove-sicular steatosis; however, there was no postreperfusion syndrome observed after revascularization of the graft and the recipient had an uneventful recovery. Liver function tests and histological examination revealed only minimal signs of hepatocellular, biliary, and endothelial cell injury during ex- situ preservation and posttransplantation.
The team led by Dr. He is to be commended for this great achieve-ment, which we consider a milestone in the history of organ transplan-tation. Even though the field of ex- situ machine perfusion in organ transplantation is rapidly emerging, all currently used protocols still include periods of cold or warm ischemia before and after the period of machine perfusion.2 With their innovative surgical technique, He
and colleagues have demonstrated that organ transplantation can be performed without any meaningful ischemia- reperfusion (IR) injury, and they have taken machine perfusion to a different level.
The worldwide shortage of donor organs has led to the increased use of extended- criteria donor organs. However, as a result of the IR injury encountered during the transplantation process, complications after trans-plantation of these organs are frequent. For this reason, many extended- criteria donor organs are still declined for transplantation. If almost all available organs could be used, in many countries the waiting list mortality would be reduced considerably. Several centers, including ours, use ma-chine perfusion as a tool to increase the number of suitable donor livers.
The innovative surgical technique described by He et al offers a unique solution for the problems with extended- criteria donor livers: no more ischemia during procurement, preservation, or graft implan-tation. We believe that within the next decade, IFOT could become the preferred preservation method for extended criteria donor organs, especially those with an increased susceptibility for IR injury, such as livers with a high degree of steatosis. However, He et al used IFOT in an organ donor in their own hospital. In centers in Europe and United States, most donor organs come from other hospitals. The machine perfusion device used by He et al is not suitable for transportation.
This is a limitation for wider adoption of this technique by other cen-ters. In addition, we believe that the current method of IFOT is surgi-cally challenging and its simplification may stimulate its introduction in other centers. For example, the use of an iliac vein graft to the portal vein requires an additional anastomosis and may theoretically increase the risk of posttransplant portal vein thrombosis. We propose a mod-ification in obtaining access to the portal venous circulation by retro-grade cannulation of a surgically reopened umbilical vein.3
DISCLOSURE
The authors of this manuscript have no conflicts of interest to dis-close as described by the American Journal of Transplantation.
Keywords
clinical research/practice, donors and donation: extended criteria, editorial/personal viewpoint, liver transplantation/hepatology, organ perfusion and preservation, organ procurement and allocation
Otto B. van Leeuwen1
Rinse Ubbink2
Vincent E. de Meijer1
Robert J. Porte1
1Department of Surgery, Section of Hepatobiliary Surgery and Liver
Transplantation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
2Groningen Transplant Center, University Medical Center
Groningen, University of Groningen, Groningen, The Netherlands
Correspondence
Robert J. Porte Email: r.j.porte@umcg.nl
REFERENCES
1. He X, Guo Z, Zhao Q, et al. The first case of ischemia- free organ transplan-tation in humans: a proof of concept. Am J Transplant. 2018;18(3):737-744. 2. Karangwa S, Dutkowski P, Fontes P, et al. Machine perfusion of donor
livers for transplantation: a proposal for standardized nomenclature and reporting guidelines. Am J Transplant. 2016;16(10):2932-2942. 3. Soyama A, Eguchi S, Takatsuki M, et al. Tumor thrombectomy via
a surgically reopened umbilical vein combined with right hemi-hepatectomy in a patient with hepatocellular carcinoma. Dig Surg. 2011;28:222-225.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
© 2018 The Authors. American Journal of Transplantation published by Wiley Periodicals, Inc. on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons